Such outcomes, in combination of earlier epidemiological evidence that MGMT promoter methylation was associated with the progression of squamous intraepithelial lesions and cervical cancer[33, 45], indicating that MGMT promoter hypermethylation may serve as an important biomarker for the progression of cervical carcinogenesis. Here, MGMT is linked to cervical cancer.